Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer-Reference-Cited by-同舟云学术

Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer

Published:2015-06-02 Issue:11 Volume:14 Page:1730-1737
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Schwaederle Maria¹,Daniels Gregory A¹,Piccioni David E¹,Kesari Santosh¹,Fanta Paul T¹,Schwab Richard B¹,Shimabukuro Kelly A¹,Parker Barbara A¹,Kurzrock Razelle¹

Affiliation:

1. Center for Personalized Cancer Therapy, and Division of Hematology and Oncology; UCSD Moores Cancer Center; La Jolla, CA, USA

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1033596

Reference42 articles.

1. Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

2. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

3. Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms

4. Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Antineoplastic Activity of a Dimer, Spiroindolinone Pyrrolidinecarboxamide;Molecules;2023-05-05

2. Integrated analysis of cell cycle-related genes in HR+/HER2− breast cancer;Breast Cancer;2021-08-27

3. Symptoms and Health-Related Quality of Life in Patients Receiving Cancer Therapy Matched to Genomic Profiles;Oncology Nursing Forum;2018-10-19

4. Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma;Journal of Cancer Research and Clinical Oncology;2018-05-04

5. Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients;Cancer;2017-12-06